Anticoagulant activities of persicarin and isorhamnetin

Vascular Pharmacology

Volumn 58, Issue 4, 2013, Pages 272-279

  Ku, Sae Kwang ^a   Kim, Tae Hoon ^a   Bae, Jong Sup ^b  

^a Daegu Haany University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Coagulation cascade; Endothelium; Fibrinolysis; Persicarin

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; ISORHAMNETIN; PERSICARIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; BLEEDING TIME; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; FEMALE; FIBRIN POLYMERIZATION; FIBRINOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; UMBILICAL VEIN ENDOTHELIAL CELL;

ADULT; ANIMALS; ANTICOAGULANTS; FACTOR XA; FEMALE; FLAVONES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED ICR; OENANTHE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; QUERCETIN; THROMBIN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84875365382     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.01.005     Document Type: Article

References (38)

1. Bae J.S., Rezaie A.R. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb. Haemost. 2008, 100:101-109.
2. Correia-da-Silva M., Sousa E., Duarte B., Marques F., Carvalho F., Cunha-Ribeiro L.M., Pinto M.M. Flavonoids with an oligopolysulfated moiety: a new class of anticoagulant agents. J. Med. Chem. 2011, 54:95-106.
3. Davie E.W. Biochemical and molecular aspects of the coagulation cascade. Thromb. Haemost. 1995, 74:1-6.
4. Davie E.W., Fujikawa K., Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991, 30:10363-10370.
5. Dejana E., Callioni A., Quintana A., de Gaetano G. Bleeding time in laboratory animals. II - a comparison of different assay conditions in rats. Thromb. Res. 1979, 15:191-197.
6. Esmon C.T. Role of coagulation inhibitors in inflammation. Thromb. Haemost. 2001, 86:51-56.
7. Furie B., Furie B.C. Thrombus formation in vivo. J. Clin. Invest. 2005, 115:3355-3362.
8. Ghosh S., Ezban M., Persson E., Pendurthi U., Hedner U., Rao L.V. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface. J. Thromb. Haemost. 2007, 5:336-346.
9. Guglielmone H.A., Agnese A.M., Nunez Montoya S.C., Cabrera J.L. Anticoagulant effect and action mechanism of sulphated flavonoids from Flaveria bidentis. Thromb. Res. 2002, 105:183-188.
10. Hamaguchi E., Takamura T., Shimizu A., Nagai Y. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells. J. Pharmacol. Exp. Ther. 2003, 307:987-994.
11. Han Y.Q., Huang Z.M., Yang X.B., Liu H.Z., Wu G.X. In vivo and in vitro anti-hepatitis B virus activity of total phenolics from Oenanthe javanica. J. Ethnopharmacol. 2008, 118:148-153.
12. Hoffman M.M., Monroe D.M. Rethinking the coagulation cascade. Curr. Hematol. Rep. 2005, 4:391-396.
13. Ji G., Yao X., Zang Z., Huang Z. Antiarrhythmic effect of Oenanthe javanica (Bl.) DC. injection. Zhongguo Zhong Yao Za Zhi 1990, 15:429-431. (448).
14. Kim J.E., Lee D.E., Lee K.W., Son J.E., Seo S.K., Li J., Jung S.K., Heo Y.S., Mottamal M., Bode A.M., Dong Z., Lee H.J. Isorhamnetin suppresses skin cancer through direct inhibition of MEK1 and PI3-K. Cancer. Prev. Res. (Phila) 2011, 4:582-591.
15. Kim T.H., Ku S.K., Bae J.S. Antithrombotic and profibrinolytic activities of eckol and dieckol. J. Cell. Biochem. 2012, 113:2877-2883.
16. Levi M., van der Poll T., Buller H.R. Bidirectional relation between inflammation and coagulation. Circulation 2004, 109:2698-2704.
17. Levi M., Schultz M., van der Poll T. Coagulation biomarkers in critically ill patients. Crit. Care Clin. 2011, 27:281-297.
18. Li Y., Qian Z.J., Ryu B., Lee S.H., Kim M.M., Kim S.K. Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorg. Med. Chem. 2009, 17:1963-1973.
19. Lopez S., Peiretti F., Bonardo B., Juhan-Vague I., Nalbone G. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 2000, 152:359-366.
20. Ma G., Yang C., Qu Y., Wei H., Zhang T., Zhang N. The flavonoid component isorhamnetin in vitro inhibits proliferation and induces apoptosis in Eca-109 cells. Chem. Biol. Interact. 2007, 167:153-160.
21. Ma C.J., Lee K.Y., Jeong E.J., Kim S.H., Park J., Choi Y.H., Kim Y.C., Sung S.H. Persicarin from water dropwort (Oenanthe javanica) protects primary cultured rat cortical cells from glutamate-induced neurotoxicity. Phytother. Res. 2010, 24:913-918.
22. Nowak P., Zbikowska H.M., Ponczek M., Kolodziejczyk J., Wachowicz B. Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications induced by peroxynitrite: functional consequences. Thromb. Res. 2007, 121:163-174.
23. Olds R.J., Lane D.A., Mille B., Chowdhury V., Thein S.L. Antithrombin: the principal inhibitor of thrombin. Semin. Thromb. Hemost. 1994, 20:353-372.
24. Olson S.T., Bjork I. Regulation of thrombin activity by antithrombin and heparin. Semin. Thromb. Hemost. 1994, 20:373-409.
25. Park J.C., Yu Y.B., Lee J.H. Isolation of steroids and flavonoids from the herb of Oenanthe javanica DC. Korean J. Pharmacogn. 1993, 24:244-246.
26. Park J.C., Young H.S., Yu Y.B., Lee J.H. Isorhamnetin sulphate from the leaves and stems of Oenanthe javanica in Korea. Planta Med. 1995, 61:377-378.
27. Philip-Joet F., Alessi M.C., Philip-Joet C., Aillaud M., Barriere J.R., Arnaud A., Juhan-Vague I. Fibrinolytic and inflammatory processes in pleural effusions. Eur. Respir. J. 1995, 8:1352-1356.
28. Quinn C., Hill J., Hassouna H. A guide for diagnosis of patients with arterial and venous thrombosis. Clin. Lab. Sci. 2000, 13:229-238.
29. Rao L.V., Rapaport S.I., Lorenzi M. Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII. Blood 1988, 71:791-796.
30. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20:933-956.
31. Sambrano G.R., Weiss E.J., Zheng Y.W., Huang W., Coughlin S.R. Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 2001, 413:74-78.
32. Schleef R.R., Bevilacqua M.P., Sawdey M., Gimbrone M.A., Loskutoff D.J. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J. Biol. Chem. 1988, 263:5797-5803.
33. Seo W.H., Baek H.H. Identification of characteristic aroma-active compounds from water dropwort (Oenanthe javanica DC.). J. Agric. Food Chem. 2005, 53:6766-6770.
34. Steffen Y., Gruber C., Schewe T., Sies H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys. 2008, 469:209-219.
35. Sugo T., Nakamikawa C., Tanabe S., Matsuda M. Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets. J. Biochem. 1995, 117:244-250.
36. Suomela J.P., Ahotupa M., Yang B., Vasankari T., Kallio H. Absorption of flavonols derived from sea buckthorn (Hippophae rhamnoides L.) and their effect on emerging risk factors for cardiovascular disease in humans. J. Agric. Food Chem. 2006, 54:7364-7369.
37. Tadera K., Minami Y., Takamatsu K., Matsuoka T. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J. Nutr. Sci. Vitaminol. (Tokyo) 2006, 52:149-153.
38. Yang X.B., Huang Z.M., Cao W.B., Zheng M., Chen H.Y., Zhang J.Z. Antidiabetic effect of Oenanthe javanica flavone. Acta Pharmacol. Sin. 2000, 21:239-242.